Have a feature idea you'd love to see implemented?
Let us know!
MRVI Maravai Lifesciences Holdings Inc
Price (delayed)
$7.13
Market cap
$1.8B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.99
Enterprise value
$1.78B
Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are
Highlights
Maravai Lifesciences Holdings's gross profit has shrunk by 65% YoY but it has increased by 8% QoQ
Maravai Lifesciences Holdings's gross margin has decreased by 32% YoY but it has increased by 6% QoQ
Maravai Lifesciences Holdings's revenue has decreased by 49% YoY
Key stats
What are the main financial stats of MRVI
Market
Valuations
Earnings
Shares outstanding
252.24M
Market cap
$1.8B
Enterprise value
$1.78B
Price to book (P/B)
4.11
Price to sales (P/S)
3.48
EV/EBIT
2.63
EV/EBITDA
2.44
EV/Sales
6.39
Revenue
$278.59M
EBIT
$676.3M
EBITDA
$730.68M
Free cash flow
-$7.93M
Per share
Balance sheet
Liquidity
EPS
-$0.99
Free cash flow per share
-$0.06
Book value per share
$1.73
Revenue per share
$2.05
TBVPS
$6.73
Total assets
$1.45B
Total liabilities
$671.19M
Debt
$554.76M
Equity
$436.93M
Working capital
$616.81M
Debt to equity
1.27
Current ratio
10
Quick ratio
8.92
Net debt/EBITDA
-0.03
Margins
Efficiency
Dividend
EBITDA margin
262.3%
Gross margin
46.7%
Net margin
-47.4%
Operating margin
-19.1%
Return on assets
-7.9%
Return on equity
-29.6%
Return on invested capital
65.7%
Return on capital employed
49%
Return on sales
242.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MRVI stock price
How has the Maravai Lifesciences Holdings stock price performed over time
Intraday
-3.26%
1 week
-12.08%
1 month
-15.62%
1 year
8.36%
YTD
8.85%
QTD
-14.2%
Financial performance
How have Maravai Lifesciences Holdings's revenue and profit performed over time
Revenue
$278.59M
Gross profit
$130.19M
Operating income
-$53.11M
Net income
-$132.08M
Gross margin
46.7%
Net margin
-47.4%
The operating margin has plunged by 148% YoY but it has increased by 7% from the previous quarter
The operating income has dropped by 125% year-on-year but it is up by 6% since the previous quarter
Maravai Lifesciences Holdings's gross profit has shrunk by 65% YoY but it has increased by 8% QoQ
Maravai Lifesciences Holdings's revenue has decreased by 49% YoY
Growth
What is Maravai Lifesciences Holdings's growth rate over time
Valuation
What is Maravai Lifesciences Holdings stock price valuation
P/E
N/A
P/B
4.11
P/S
3.48
EV/EBIT
2.63
EV/EBITDA
2.44
EV/Sales
6.39
The company's equity fell by 16% YoY but it rose by 6% QoQ
MRVI's price to book (P/B) is 11% less than its last 4 quarters average of 4.6
Maravai Lifesciences Holdings's revenue has decreased by 49% YoY
Efficiency
How efficient is Maravai Lifesciences Holdings business performance
The company's return on invested capital rose by 19% QoQ
The return on assets has declined by 13% since the previous quarter
The return on equity has declined by 5% since the previous quarter
Dividends
What is MRVI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MRVI.
Financial health
How did Maravai Lifesciences Holdings financials performed over time
MRVI's total assets is 116% greater than its total liabilities
The total liabilities has plunged by 51% YoY
MRVI's total assets is down by 36% year-on-year
The company's debt is 27% higher than its equity
Maravai Lifesciences Holdings's debt to equity has increased by 19% YoY but it has decreased by 6% QoQ
The company's equity fell by 16% YoY but it rose by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.